Mehta, Rohtesh S.
Bassett, Roland
Rondon, Gabriela
Overman, Bethany J.
Popat, Uday R.
Hosing, Chitra M.
Rezvani, Katy
Qazilbash, Muzaffar H. http://orcid.org/0000-0003-2876-2886
Anderlini, Paolo
Jones, Roy B.
Kebriaei, Partow http://orcid.org/0000-0002-8607-9404
Marin, David
Khouri, Issa F.
Oran, Betul
Ciurea, Stefan O.
Kondo, Kayo
Couriel, Daniel R.
Shpall, Elizabeth J.
Champlin, Richard E. http://orcid.org/0000-0002-4314-5037
Alousi, Amin M. http://orcid.org/0000-0002-2498-8573
Funding for this research was provided by:
This physician-initiated trial was supported by a grant from Therakos, Inc., a Mallinckrodt Pharmaceuticals company.
National Cancer Center (NCI Grant P30 CA016672)
Article History
Received: 22 August 2020
Revised: 1 October 2020
Accepted: 2 December 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: AMA has served as a speaker for Therakos, Inc. Other authors declare no conflict of interest.